1. Home
  2. GPCR vs PLAB Comparison

GPCR vs PLAB Comparison

Compare GPCR & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • PLAB
  • Stock Information
  • Founded
  • GPCR 2016
  • PLAB 1969
  • Country
  • GPCR United States
  • PLAB United States
  • Employees
  • GPCR N/A
  • PLAB N/A
  • Industry
  • GPCR
  • PLAB Semiconductors
  • Sector
  • GPCR
  • PLAB Technology
  • Exchange
  • GPCR Nasdaq
  • PLAB Nasdaq
  • Market Cap
  • GPCR 1.8B
  • PLAB 1.6B
  • IPO Year
  • GPCR 2023
  • PLAB 1987
  • Fundamental
  • Price
  • GPCR $40.36
  • PLAB $23.36
  • Analyst Decision
  • GPCR Buy
  • PLAB
  • Analyst Count
  • GPCR 6
  • PLAB 0
  • Target Price
  • GPCR $81.33
  • PLAB N/A
  • AVG Volume (30 Days)
  • GPCR 593.8K
  • PLAB 452.3K
  • Earning Date
  • GPCR 08-08-2024
  • PLAB 08-29-2024
  • Dividend Yield
  • GPCR N/A
  • PLAB N/A
  • EPS Growth
  • GPCR N/A
  • PLAB 18.80
  • EPS
  • GPCR N/A
  • PLAB 2.27
  • Revenue
  • GPCR N/A
  • PLAB $871,791,000.00
  • Revenue This Year
  • GPCR N/A
  • PLAB N/A
  • Revenue Next Year
  • GPCR N/A
  • PLAB $9.01
  • P/E Ratio
  • GPCR N/A
  • PLAB $10.43
  • Revenue Growth
  • GPCR N/A
  • PLAB N/A
  • 52 Week Low
  • GPCR $26.61
  • PLAB $18.03
  • 52 Week High
  • GPCR $75.02
  • PLAB $34.16
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 57.92
  • PLAB 49.35
  • Support Level
  • GPCR $38.27
  • PLAB $21.66
  • Resistance Level
  • GPCR $42.67
  • PLAB $23.93
  • Average True Range (ATR)
  • GPCR 2.29
  • PLAB 0.88
  • MACD
  • GPCR 0.31
  • PLAB 0.01
  • Stochastic Oscillator
  • GPCR 76.72
  • PLAB 40.33

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue worldwide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

Share on Social Networks: